this is the best part of Today's announcement.
CT:VQ™ is set to disrupt a billion dollar segment of respiratory diagnostics by displacing Nuclear VQ imaging with a technology that is faster, safer, cheaper, more convenient and more accessible. We have been working for some time, leveraging hard fought experience with existing products, to build an aggressive market adoption strategy, and this contract win with the DoD, prior to FDA clearance, is testament to that work and the clear competitive advantages of our product.
- Forums
- ASX - By Stock
- Ann: US DoD to conduct paid CT VQ pilot ahead of FDA submission
4DX
4dmedical limited
Add to My Watchlist
0.00%
!
25.0¢

this is the best part of Today's announcement. CT:VQ™ is set to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $116.3M |
Open | High | Low | Value | Volume |
25.5¢ | 25.5¢ | 25.0¢ | $192.8K | 760.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 219887 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 19890 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 219887 | 0.250 |
6 | 645027 | 0.245 |
16 | 474238 | 0.240 |
6 | 54965 | 0.235 |
9 | 46607 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 19890 | 1 |
0.260 | 50300 | 2 |
0.265 | 59622 | 2 |
0.270 | 150246 | 3 |
0.275 | 50000 | 2 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
4DX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online